Hidemaru Yamaguchi

Q: How accurate are Hidemaru Yamaguchi's stock ratings?

About 68% of Hidemaru's ratings were profitable over a one-year hold, with an average return of +10.5% per rating, measured by 13Foresight from historical prices.

Q: How is Hidemaru ranked?

Hidemaru Yamaguchi is ranked #993 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Citi

Wall Street Analyst

★★★☆☆

#993

on 13Foresight · ranked by our own returns

71%

Success Rate

+10.3%

Average Return

20 of 28 calls profitable · -5.1% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 71% of Hidemaru Yamaguchi's ratings turned a profit when each position was held for 1 year — averaging +10.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

9 Buy 7 Hold 3 Sell

Hidemaru's Stock Coverage 26 ratings · 2026-08-29

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
JP:4503 Astellas Pharma	Aug 07, 2026	HOLD	Buy -8.5% avg upside 6 analysts	$2470.00 4.21% Upside	+0.3%	·
JP:4587 Peptidream	Jul 22, 2026	HOLD	Buy +95.8% avg upside 3 analysts	$1100.00 1.22% Downside	+17.0%	·
JP:4592 SanBio Co	Jul 16, 2026	BUY	Strong Buy +88.9% avg upside 2 analysts	$1800.00 74.35% Upside	-0.3%	·
JP:4506 Sumitomo Dainippon Pharma Co	May 25, 2026	SELL	Buy +20.1% avg upside 4 analysts	$1500.00 0.99% Upside	+3.9%	·
JP:2503 Kirin Holdings Company	Apr 03, 2026	HOLD	Hold -12.7% avg upside 6 analysts	$2800.00 8.35% Downside	+18.1%	·
JP:4151 Kyowa Kirin Co	Mar 10, 2026	SELL	Sell -20.7% avg upside 5 analysts	$2000.00 24.99% Downside	-17.6%	·
JP:2413 M3	Feb 09, 2026	BUY	Strong Buy +22.7% avg upside 2 analysts	$2800.00 51.00% Upside	+7.1%	·
JP:4552 JCR Pharmaceuticals Co., Ltd.	Feb 05, 2026	HOLD	Hold +22.5% avg upside 2 analysts	$670.00 23.48% Upside	-14.0%	·
JP:4568 Daiichi Sankyo Company	Feb 05, 2026	BUY	Strong Buy +50.6% avg upside 7 analysts	$4900.00 67.11% Upside	+3.5%	·
JP:4565 Sosei Group	Nov 28, 2025	BUY	Strong Buy +42.6% avg upside 2 analysts	$1400.00 24.84% Upside	+32.5%	·
JP:4523 Eisai Co	Sep 12, 2025	BUY	Buy +4.9% avg upside 6 analysts	$6200.00 28.57% Upside	-3.9%	·
JP:4543 Terumo	Aug 29, 2025	BUY	Strong Buy +47.9% avg upside 5 analysts	$3900.00 53.67% Upside	-4.1%	·
JP:7747 Asahi Intecc Co	Aug 29, 2025	BUY	Strong Buy -8.2% avg upside 3 analysts	$3500.00 8.09% Downside	+47.6%	·
JP:4528 ONO Pharmaceutical Co	Aug 28, 2025	HOLD	Sell -21.1% avg upside 4 analysts	$1750.00 28.78% Downside	+54.2%	·
JP:4578 Otsuka Holdings Co	Aug 27, 2025	BUY	Strong Buy -3.4% avg upside 7 analysts	$10500.00 13.65% Downside	+57.9%	·
JP:4516 Nippon Shinyaku Co., Ltd.	Aug 26, 2025	BUY	Buy +8.9% avg upside 4 analysts	$4600.00 28.01% Upside	+18.5%	·
JP:4536 Santen Pharmaceutical Co	Aug 22, 2025	BUY	Strong Buy +24.5% avg upside 3 analysts	$2600.00 40.69% Upside	+24.7%	·
JP:4553 Towa Pharmaceutical Co	Aug 22, 2025	BUY	Strong Buy -11.0% avg upside 1 analyst	$3500.00 10.96% Downside	+29.8%	·
JP:6523 PHC Holdings Corp.	Jun 26, 2025	HOLD	Hold -36.4% avg upside 2 analysts	$960.00 37.72% Downside	+15.2%	·
JP:7459 Medipal Holdings	Jun 26, 2025	HOLD	Hold -16.4% avg upside 1 analyst	$2410.00 16.41% Downside	+15.6%	·
JP:4886 ASKA Pharmaceutical Holdings Co., Ltd.	Jun 24, 2025	HOLD	Hold +22.8% avg upside 1 analyst	$2600.00 22.83% Upside	-4.5%	·
JP:4519 Chugai Pharmaceutical Co	May 27, 2025	BUY	Strong Buy +36.4% avg upside 6 analysts	$12000.00 70.59% Upside	+6.9%	·
JP:4507 Shionogi & Co	May 21, 2025	BUY	Buy -6.3% avg upside 6 analysts	$2800.00 3.77% Downside	+28.7%	·
JP:6869 Sysmex	Nov 26, 2024	HOLD	Buy +25.3% avg upside 3 analysts	$3300.00 68.79% Upside	-51.4%	·
HTHIY Hitachi	Mar 29, 2010	BUY	Buy 3 analysts	—	+31.1%	·
SMFG Sumitomo Mitsui	Nov 18, 2009	HOLD	Hold 2 analysts	—	+2.6%	·

🔒 21 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Hidemaru Yamaguchi — Frequently Asked Questions

How accurate are Hidemaru Yamaguchi's stock ratings?

Based on the calls 13Foresight could measure, about 68% of Hidemaru's ratings were profitable over a one-year hold, with an average return of +10.5% per rating, or -4.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Hidemaru ranked on 13Foresight?

Hidemaru Yamaguchi is currently ranked #993 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Hidemaru cover?

Hidemaru most recently has ratings on JP:4503, JP:4587, JP:4592, JP:4506, JP:2503, JP:4151, JP:2413, JP:4552, JP:4568, JP:4565, JP:4523, JP:4543 and 14 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Hidemaru Yamaguchi

Rating Distribution

Welcome to 13Foresight!